These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 39118031)

  • 1. Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.
    Fuentes JJ; Mayans J; Guarro M; Canosa I; Mestre-Pintó JI; Fonseca F; Torrens M
    BMC Psychiatry; 2024 Aug; 24(1):551. PubMed ID: 39118031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress.
    Gowatch LC; Evanski JM; Ely SL; Zundel CG; Bhogal A; Carpenter C; Shampine MM; O'Mara E; Mazurka R; Barcelona J; Mayo LM; Marusak HA
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):1217-1234. PubMed ID: 38683635
    [No Abstract]   [Full Text] [Related]  

  • 4. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume.
    Mazurka R; Harkness KL; Hassel S; Stensson N; Nogovitsyn N; Poppenk J; Foster JA; Squires SD; Rowe J; Milev RV; Wynne-Edwards KE; Turecki G; Strother SC; Arnott SR; Lam RW; Rotzinger S; Kennedy SH; Frey BN; Mayo LM
    Transl Psychiatry; 2024 Oct; 14(1):431. PubMed ID: 39394160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use.
    Kroll SL; Meier P; Mayo LM; Gertsch J; Quednow BB
    Neuropsychopharmacology; 2024 Sep; 49(10):1630-1639. PubMed ID: 38773316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
    Hill MN; Miller GE; Carrier EJ; Gorzalka BB; Hillard CJ
    Psychoneuroendocrinology; 2009 Sep; 34(8):1257-62. PubMed ID: 19394765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
    Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy.
    Bloemhof-Bris E; Meiri D; Sulimani L; Genesh SN; Wexler G; Cohen I; Salama A; Burshtein I; Hirschmann S; Feffer K; Weizman S; Stryjer R; Shelef A
    Psychiatry Res; 2024 Jul; 337():115967. PubMed ID: 38796933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIONOTE as an Innovative Biosensor for Measuring Endocannabinoid Levels.
    Grasso S; Santonico M; Pennazza G; Zompanti A; Piccoli A; Bisogno T; Maccarrone M
    Sensors (Basel); 2021 Jan; 21(2):. PubMed ID: 33445599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report.
    Hill MN; Miller GE; Ho WS; Gorzalka BB; Hillard CJ
    Pharmacopsychiatry; 2008 Mar; 41(2):48-53. PubMed ID: 18311684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity.
    Gebeh AK; Willets JM; Bari M; Hirst RA; Marczylo TH; Taylor AH; Maccarrone M; Konje JC
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1226-34. PubMed ID: 23372171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans.
    Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G
    Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.
    Jumpertz R; Wiesner T; Blüher M; Engeli S; Bátkai S; Wirtz H; Bosse-Henck A; Stumvoll M
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):591-5. PubMed ID: 20429051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence.
    Garcia-Marchena N; Pavon FJ; Pastor A; Araos P; Pedraz M; Romero-Sanchiz P; Calado M; Suarez J; Castilla-Ortega E; Orio L; Boronat A; Torrens M; Rubio G; de la Torre R; Rodriguez de Fonseca F; Serrano A
    Addict Biol; 2017 Sep; 22(5):1366-1377. PubMed ID: 27212249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endocannabinoid concentrations in grieving adults.
    Harfmann EJ; McAuliffe TL; Larson ER; Claesges SA; Sauber G; Hillard CJ; Goveas JS
    Psychoneuroendocrinology; 2020 Oct; 120():104801. PubMed ID: 32682172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endocannabinoids and affect regulation in human subjects.
    Coccaro EF; Hill MN; Robinson L; Lee RJ
    Psychoneuroendocrinology; 2018 Jun; 92():66-71. PubMed ID: 29627714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms are negatively associated with hair N-arachidonoylethanolamine (anandamide) levels: A cross-lagged panel analysis of four annual assessment waves examining hair endocannabinoids and cortisol.
    Walther A; Kirschbaum C; Wehrli S; Rothe N; Penz M; Wekenborg M; Gao W
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110658. PubMed ID: 36252885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.